NL-OMON23593招募中不适用
Prospective Randomised study on imiquimod 5% cream as pretreatment of Mohs micrographic surgery for primary large nodular basal cell carcinoma in the face to reduce the post-Mohs defect size.
Drs S van der Geer.No sponsors.0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients > 18 years;
- •2. Primary BCC, nodular or nodular and partially superficial;
排除标准
- •1. Pregnant women;
- •2. Women who breastfeed;
研究者
相似试验
已完成
4 期
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and HandsKeratosisNCT00115154Graceway Pharmaceuticals, LLC270
已完成
3 期
Safety and Effectiveness Study of Actinic Keratosis Treatment Following CryosurgeryActinic KeratosisNCT00894647Graceway Pharmaceuticals, LLC247
Unknown
4 期
Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic KeratosisActinic KeratosisNCT01413763Medicis Global Service Corporation50
已完成
1 期
Bioequivalence Study of Two Imiquimod Cream 5%Actinic KeratosisNCT00828568Taro Pharmaceuticals USA425
已完成
3 期
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital WartsGenital WartsNCT00674739Graceway Pharmaceuticals, LLC470